In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Decision making in patients with multivalvular disease

Meet the Experts session

  • Aortic stenosis and mitral regurgitation: challenges for assessment and decision-making, presented by P Lancellotti (Liege, BE)
  • A patient with a combined aortic stenotic and regurgitant lesion, presented by J-L Monin (Creteil, FR) - Slides
  • What do the Guidelines say? Presented by R Rosenhek (Vienna, AT) - Slides
Valvular Heart Diseases

With an ageing population and an increasing incidence of valvular heart disease, the number of patients presenting with more complex and multivalvular affection is becoming increasingly common. Combined valve disease was traditionally observed in rheumatic disease but is increasingly found in degenerative disease.

Aortic stenosis and mitral regurgitation: challenges for assessment and decision-making

In the present session, issues of disease assessment and management were discussed based on two clinical cases. The first case was a patient with aortic stenosis and concomitant mitral regurgitation. The major pitfalls of this case included a reduction of forward stroke volume across the aortic valve due to the regurgitant volume through the mitral valve. With regard to decision-making, in the presence of an indication for aortic valve surgery, the severity of mitral regurgitation, its etiology (functional vs. organic) as well as the increased risk of surgery on a second valve needs to be considered.

A patient with a combined aortic stenotic and regurgitant lesion

The second case consisted of a significantly symptomatic patient with combined stenotic and regurgitant aortic valve disease. Based on a calculated aortic valve area of 1.3 cm2 and a peak aortic jet velocity of 4.3 m/s, aortic stenosis was quantified as moderate and aortic regurgitation as being severe. This case illustrates the fact that advanced symptoms may occur in multiple valve disease, although the contributing part of each single lesion is variable.

What do the Guidelines say?

Due to a lack of data, current guidelines are not able to provide evidence-based recommendations. In principle, recommendations for each single valve disease should be followed and the interactions between the different lesions have to be considered. Symptoms are an important factor that has to be considered in decision-making process. The decision to intervene on multiple valves should account for the extra surgical risk of combined procedures.




Decision making in patients with multivalvular disease

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.